- Home
- ATRA vs GROW Comparison
ATRA vs GROW Comparison
Compare ATRA & GROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ATRA | GROW |
|---|---|---|
| Founded | 2012 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.9M | 31.3M |
| IPO Year | 2014 | 1995 |
Fundamental Metrics
Financial Performance| Metric | ATRA | GROW |
|---|---|---|
| Price | $5.18 | $2.53 |
| Analyst Decision | Sell | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $5.00 | N/A |
| AVG Volume (30 Days) | ★ 90.8K | 30.6K |
| Earning Date | 05-14-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 3.57% |
| EPS Growth | ★ 122.52 | N/A |
| EPS | ★ 2.57 | 0.05 |
| Revenue | ★ $120,772,000.00 | $23,850,609.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $1.90 | $50.40 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.92 | $2.07 |
| 52 Week High | $19.15 | $3.65 |
Technical Indicators
Market Signals| Indicator | ATRA | GROW |
|---|---|---|
| Relative Strength Index (RSI) | 51.10 | 34.01 |
| Support Level | $4.14 | $2.35 |
| Resistance Level | $5.55 | $2.58 |
| Average True Range (ATR) | 0.45 | 0.14 |
| MACD | 0.05 | -0.01 |
| Stochastic Oscillator | 83.81 | 17.00 |
Price Performance
Historical ComparisonAbout ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).
About GROW U.S. Global Investors Inc.
US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.